本文選題：三陰性乳腺癌 + 超聲聲像圖��； 參考：《中國(guó)老年學(xué)雜志》2016年13期

【摘要】：目的探討三陰性乳腺癌超聲征象及臨床、病理特征并與非三陰性乳腺癌比較。方法回顧性分析經(jīng)病理證實(shí)乳腺癌313例資料,根據(jù)術(shù)后免疫組化染色結(jié)果,對(duì)比分析三陰性乳腺癌(n=33)組與非三陰性乳腺癌(n=280)組超聲征象及臨床、病理特征。結(jié)果超聲結(jié)果:與非三陰性乳腺癌比較,三陰性乳腺癌呈現(xiàn)良性腫瘤特征,外形顯示分葉狀及微分葉狀,后方回聲增強(qiáng)、衰減減少,周邊聲暈減少,微鈣化減少均具有統(tǒng)計(jì)學(xué)意義(P0.05)。病理結(jié)果:三陰性乳腺癌組腋窩淋巴結(jié)轉(zhuǎn)移率高于非三陰性乳腺癌組(P=0.004)。臨床顯示:三陰性乳腺癌組發(fā)病年齡較非三陰性乳腺癌組無(wú)差異(P=0.026)。結(jié)論三陰性乳腺癌與非三陰性乳腺癌有一些不同的超聲征象,這些征象貌似良性腫物特征,了解這些特征有助于檢查者避免三陰性乳腺癌的假陰性診斷。
[Abstract]:Objective to investigate the ultrasonographic features and clinical and pathological features of triple negative breast cancer and to compare them with non-triple-negative breast cancer. Methods the data of 313 cases of breast cancer confirmed by pathology were retrospectively analyzed. According to the results of immunohistochemical staining, the ultrasonographic features, clinical and pathological features of the tri-negative breast cancer group and the non-tri-negative breast cancer group were compared. Results: compared with non-triple-negative breast cancer, triple-negative breast cancer showed benign tumor features with lobular and differential lobular appearance, enhanced posterior echo, decreased attenuation, and decreased peripheral acoustics. The decrease of microcalcification was statistically significant (P 0.05). Pathological results: the rate of axillary lymph node metastasis in tri-negative breast cancer group was higher than that in non-triple-negative breast cancer group. The clinical results showed that there was no difference in age of three negative breast cancer patients compared with non-triple-negative breast cancer group (P 0. 026). Conclusion Tri-negative breast cancer and non-triple-negative breast cancer have some different ultrasonic signs, which appear to be benign tumor features. Understanding these features is helpful to avoid false negative diagnosis of triple-negative breast cancer.
【作者單位】： 天津市第四中心醫(yī)院超聲科;
【分類號(hào)】：R737.9;R445.1

【相似文獻(xiàn)】

相關(guān)期刊論文 前6條

1 張妍;王f^星;王峻;黃永波;王艷軍;;WB-DWI在惡性腫瘤淋巴結(jié)轉(zhuǎn)移中的應(yīng)用[J];中國(guó)中西醫(yī)結(jié)合影像學(xué)雜志;2013年03期

2 蔣寧;胃癌及淋巴結(jié)轉(zhuǎn)移的B超診斷與分類[J];中國(guó)醫(yī)學(xué)影像技術(shù);1993年01期

3 馮仕庭;周健;李子平;孫燦輝;;USPIO在直腸癌淋巴結(jié)轉(zhuǎn)移MRI診斷中的研究進(jìn)展[J];國(guó)際醫(yī)學(xué)放射學(xué)雜志;2010年06期

4 朱蘭;潘自來(lái);;磁共振彌散加權(quán)成像在直腸癌淋巴結(jié)轉(zhuǎn)移評(píng)估中的價(jià)值綜述[J];CT理論與應(yīng)用研究;2014年03期

5 解敬慧;郜瑩;陳博;付澗蘭;張延軍;;非小細(xì)胞肺癌原發(fā)灶~(18)F-FDG PET/CT特征預(yù)測(cè)淋巴結(jié)轉(zhuǎn)移[J];中國(guó)醫(yī)學(xué)影像技術(shù);2014年05期

6 ;[J];;年期

相關(guān)會(huì)議論文 前1條

1 石峰;秦昂;;~(125)I粒子治療惡性淋巴結(jié)轉(zhuǎn)移瘤臨床觀察[A];中華醫(yī)學(xué)會(huì)第九次全國(guó)核醫(yī)學(xué)學(xué)術(shù)會(huì)議論文摘要匯編[C];2011年

，

本文編號(hào)：1880489